Literature DB >> 10320209

Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs.

U Kuenstler1, U Juhnhold, W H Knapp, H J Gertz.   

Abstract

We investigated the relationship between fine extrapyramidal-motor symptoms (reduction of handwriting area) and D2 dopamine receptor occupancy under neuroleptic treatment. The handwriting of 18 schizophrenic patients before and during treatment with typical (haloperidol, haloperidol decanoate) and atypical (clozapine, risperidone) neuroleptic drugs was examined. Data analysis of the handwriting's examination was carried out with a planimetric computer programme. At the time of the second test of handwriting, D2 receptor occupancy was determined with single photon emission tomography (SPET) using [(123)I]iodobenzamide ((123)I-IBZM). In all patients, a reduction of handwriting area and a D2 receptor occupancy were found. The correlation between reduction of handwriting area and D2 receptor occupancy for typical and atypical neuroleptic drugs was linear and statistically significant (r=0.9; P > 0.001). Our findings point to the possibility that the reduction of handwriting area may be used as a clinical indicator of D2 receptor occupancy under treatment with neuroleptic drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320209     DOI: 10.1016/s0925-4927(98)00054-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James B Lohr
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

2.  Do doctors agree on doses of antipsychotic medications?

Authors:  Johan Schill; Hans Olsson
Journal:  Ther Adv Psychopharmacol       Date:  2016-08-08

3.  A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; James B Lohr
Journal:  J Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.153

4.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

5.  Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James Lohr
Journal:  Hum Mov Sci       Date:  2009-08-18       Impact factor: 2.161

6.  A novel magnetic stimulator increases experimental pain tolerance in healthy volunteers - a double-blind sham-controlled crossover study.

Authors:  Rudie Kortekaas; Lotte E van Nierop; Veroni G Baas; Karl-Heinz Konopka; Marten Harbers; Johannes H van der Hoeven; Marten van Wijhe; André Aleman; Natasha M Maurits
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

7.  Examining Motor Anticipation in Handwriting as an Indicator of Motor Dysfunction in Schizophrenia.

Authors:  Yasmina Crespo Cobo; Sonia Kandel; María Felipa Soriano; Sergio Iglesias-Parro
Journal:  Front Psychol       Date:  2022-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.